Table 2 Patients characteristics at the time of quaternary debulking surgery (QDS)
Author | Year | Number | FIGO stage (n) | Agea | Residual disease (n) | Median CA125 (U/ml) | Chemotherapy (n) | Median OS (m)b |
|---|---|---|---|---|---|---|---|---|
Shih et al. | 2010 | 15 | I (1) | 54.1 | 0 mm (10) | NA | Yes (9) | 34.8, 10.1 (from TDS)c |
II (2) | >0 mm (5) | No (6) | ||||||
III (9) | ||||||||
IV (1) | ||||||||
Fotopoulou et al. | 2013 | 49 | I (6) | 57 | 0 mm (16) | 736 | Yes (18) | 23.05 (from QDS) |
II (6) | >0 mm (33) | No (31) | ||||||
III (33) | ||||||||
IV (1) | ||||||||
Bacarubasa et al. | 2015 | 20 | I (4) | 54.3 | 0 mm (7) | NA | NA | 16 (from QDS) |
II (5) | >0 mm (13) | |||||||
III (11) | ||||||||
IV (0) | ||||||||
Hirakawa et al. | 2017 | 11 | I (0) | 57 | 0 mm (7) | 11.2 (6 cases) | Yes (4) | 123 (from SDS) |
II (1) | >0 mm (2) | No (7) | ||||||
III (7) | Missing (2) | |||||||
IV (3) |